17
Sep
Sep
The U.S. Food and Drug Administration has approved an eczema drug from Eli Lilly, providing a novel treatment option for people with moderate to severe atopic dermatitis that doesn’t respond to prescription topical medications. Atopic dermatitis is a common form eczema which causes droughty, itchy, scaly patches of skin. It is the most common chronic […]